Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Integral Health Asset Management, LLC
Form 13F · Q2 2026

Integral Health Asset Management, LLC

CIK 1773206Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$2.5B
Reported book value
92
Positions
12
Quarters on record
Top 50
Positions

Integral Health Asset Management, LLC — holdings

Top 50 positions of 92, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1RVMD Revolution Medicines Inc1.5M+0.0%$281M11.1%
2INSM Insmed Inc1.6M+6.7%$171M6.7%
3CYTK Cytokinetics Inc1.6M+0.0%$136M5.4%
4CVS Cvs Health Corp1.1M+633.3%$114M4.5%
5EWTX Edgewise Therapeutics Inc2.0M+25.0%$81M3.2%
6VERA Vera Therapeutics Inc1.8M+9.4%$75M3.0%
7AXSM Axsome Therapeutics Inc.300,000+757.1%$73M2.9%
8CAH Cardinal Health Inc300,000+11.1%$71M2.8%
9ROIV Roivant Sciences Ltd2.0M+0.0%$71M2.8%
10RYTM Rhythm Pharmaceuticals Inc550,000−8.3%$61M2.4%
11EW Edwards Lifesciences Corp625,000+267.6%$57M2.2%
12ALHC Alignment Healthcare Inc2.0M−22.3%$48M1.9%
13MRK Merck & Co Inc350,000−17.6%$45M1.8%
14DGX Quest Diagnostics Inc200,000+233.3%$42M1.7%
15UNIQURE NV Uniqure Nv900,000+0.0%$41M1.6%
16SRRK Scholar Rock Hldg Corp750,000+50.0%$41M1.6%
17BSX Boston Scientific Corp900,000+63.6%$38M1.5%
18BRIGHTSPRING HEALTH SVCS INC Brightspring Health Svcs Inc550,000−56.0%$38M1.5%
19ABT Abbott Laboratories400,000—$36M1.4%
20UNH Unitedhealth Group Inc85,000—$35M1.4%
21LFST Lifestance Health Group Inc3.0M−30.2%$32M1.3%
22NVS Novartis Ag200,000−20.0%$31M1.2%
23TNGX Tango Therapeutics Inc1.0M+122.2%$31M1.2%
24THC Tenet Healthcare Corp165,000—$31M1.2%
25SYRE Spyre Therapeutics Inc325,000—$29M1.1%
26NVO Novo-Nordisk A S600,000—$29M1.1%
27DFTX Definium Therapeutics Inc550,000+37.5%$26M1.0%
28NBIX Neurocrine Biosciences Inc150,000+0.0%$25M1.0%
29REGN Regeneron Pharmaceuticals40,000−52.9%$25M1.0%
30BIIB Biogen Inc100,000+66.7%$22M0.9%
31TVTX Travere Therapeutics Inc375,000—$21M0.8%
32LNTH Lantheus Hldgs Inc190,000+52.0%$21M0.8%
33GKOS Glaukos Corp150,000−14.3%$21M0.8%
34ORIC Oric Pharmaceuticals Inc1.9M+35.7%$21M0.8%
35BBIO Bridgebio Pharma Inc275,000+0.0%$20M0.8%
36VERTEX PHARMACEUTICALS INC Vertex Pharmaceuticals Inc40,000+0.0%$20M0.8%
37ALMS Alumis Inc700,000−12.5%$20M0.8%
38ELV Elevance Health Inc Formerly50,000−33.3%$19M0.8%
39CNC Centene Corp Del300,000−53.8%$19M0.8%
40ERAS Erasca Inc1.0M+42.9%$18M0.7%
41LLY Eli Lilly & Co15,000+0.0%$18M0.7%
42ARWR Arrowhead Pharmaceuticals In200,000−33.3%$16M0.6%
43NVST Envista Holdings Corporation600,000+71.4%$16M0.6%
44MDT Medtronic Plc200,000—$16M0.6%
45WATERS CORP Waters Corp40,000—$15M0.6%
46LIVN Livanova Plc180,000+20.0%$15M0.6%
47FORTE BIOSCIENCES INC Forte Biosciences Inc675,000+350.0%$14M0.6%
48MDGL Madrigal Pharmaceuticals Inc25,000+0.0%$13M0.5%
49PRAX Praxis Precision Medicines I40,000+0.0%$13M0.5%
50ANRO Alto Neuroscience Inc500,000+0.0%$13M0.5%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.